aibioPurple Biotech regains Nasdaq minimum bid price compliance
Tickers PPBT
The ADSs held a closing bid of $1.00 or more for at least 10 consecutive business days, reached on March 13, 2026. The company is now compliant with applicable listing standards.
Key facts
- Company
- Purple Biotech Ltd. (TASE: PPBT)
- News type
- Listings
- Primary source
- Purple Biotech Ltd. 6-K (2026-03-17)
Purple Biotech Ltd. said on March 17, 2026 that it received confirmation from the Listing Qualifications Department of The Nasdaq Stock Market LLC that it has regained compliance with the minimum bid price requirement. The rule is Nasdaq Listing Rule 5550(a)(2), which applies to continued listing on The Nasdaq Capital Market.
To regain compliance, the company had to keep a closing bid price for its American Depositary Shares (ADSs) of $1.00 per share or more for at least 10 consecutive business days. It reached that on March 13, 2026.
Purple Biotech says it is now compliant with the applicable listing standards for continued Nasdaq listing. The company's securities trade on both Nasdaq and the Tel Aviv Stock Exchange under the symbol PPBT.